Nonclassical transport proteins and peptides: An alternative to classical macromolecule delivery systems

Journal of Pharmaceutical Sciences

Volumn 92, Issue 9, 2003, Pages 1754-1772

  Kueltzo, Lisa A ^a,b   Middaugh, C Russell ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Cell penetrating peptides; Delivery; Nonclassical transport; Penetratin; Tat; VP22

Indexed keywords

AROMATIC AMINO ACID; CARRIER PROTEIN; CELL PENETRATING PEPTIDE; DNA; FIBROBLAST GROWTH FACTOR; HOMEODOMAIN PROTEIN; MEMBRANE PROTEIN; PEPTIDE; POLYANION; POLYCATION; PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VP 22 PROTEIN;

BILAYER MEMBRANE; DRUG DELIVERY SYSTEM; MACROMOLECULE; PROTEIN TRANSPORT; SHORT SURVEY; TECHNOLOGY;

EID: 0042839354     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10448     Document Type: Short Survey

References (179)

1. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. 1994. Vesicular traffic in the secretory and endocytotic pathways. Molecular biology of the cell, 3rd ed. New York: Garland Publishing, Inc., pp 604-654.
2. Gorlich D, Mattaj IW. 1996. Nucleocytoplasmic transport. Science 271:1513-1518.
3. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. 1994. Intercellular components and protein sorting. Molecular biology of the cell, 3rd ed. New York: Garland Publishing, Inc., pp 551-599.
4. Stephens DJ, Pepperkok R. 2001. The many ways to cross the plasma membrane. Proc Natl Acad Sci USA 98:4295-4298.
5. Sandig V, Strauss M. 1997. Virus functions for artificial vectors. In: Strauss M, Barranger JA, editors. Concepts in gene therapy. Berlin: Walter de Gruyter & Co., pp 79-97.
6. Jolly DJ. 1999. Emerging viral vectors. In: Friedmann T, editor. The development of human gene therapy. New York: Cold Spring Harbor Laboratory Press, pp 209-240.
7. Lasic DD. 1997. Liposomes in gene delivery. Boca Raton, FL: CRC Press.
8. Zelphati O, Wang Y, Kitada S, Reed JC, Felgner PL, Corbeil J. 2001. Intracellular delivery of proteins with a new lipid-mediated delivery system. J Biol Chem 276:35103-35110.
9. Patri AK, Majoros IJ, Baker JR. 2002. Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol 6:466-471.
10. Godbey WT, Wu KK, Mikos AG. 1999. Poly(ethylenimine) and its role in gene delivery. J Control Release 60:149-160.
11. Ragin A, Morgan R, Chmielewski J. 2002. Cellular import mediated by nuclear localization signal peptide sequences. Chem Biol 9:943.
12. Chan CK, Jans DA. 2002. Using nuclear targeting signals to enhance non-viral gene transfer. Immunol Cell Biol 80:119-130.
13. Lindgren M, Hallbrink M, Prochiantz A, Langel U. 2000. Cell-penetrating peptides. Trends Pharmacol Sci 21:99-103.
14. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y. 2001. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276:5836-5840.
15. Singh M, Briones M, Ott G, O'Hagan D. 2000. Cationic microparticles: A potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 97: 811-816.
16. Kueltzo LA, Middaugh CR. 2000. Potential use of non-classical pathways for the transport of macromolecular drugs. Exp Opin Invest Drugs 9:2039-2050.
17. Prochiantz A. 2000. Messenger proteins: Homeoproteins, TAT and others. Curr Opin Cell Biol 12: 400-406.
18. Rubartelli A, Sitia R. 1997. Secretion of mammalian proteins that lack a signal sequence. In: Kuchler K, editor. Unusual secretory pathways: From bacteria to man. Austin, TX: R.G. Landes Bioscience, pp 87-114.
19. Rubartelli A, Cozzolino F, Talio M, Sitia R. 1990. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J 9: 1503-1510.
20. Abraham JA, Mergia A, Whang JL, Tumolo A, Friedman J, Hjerrild KA, Gospodarowicz D, Fiddes JC. 1986. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233:545-548.
21. Reiness CG, Seppa MJ, Dion DM, Sweeney S, Foster DN, Nishi R. 2001. Chick ciliary neurotrophic factor is secreted via a nonclassical pathway. Mol Cell Neurosci 17:931-944.
22. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J. 1994. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 91:664-668.
23. Perez F, Lledo PM, Karagogeos D, Vincent JD, Prochiantz A, Ayala J. 1994. Rab3A and Rab3B carboxy-terminal peptides are both potent and specific inhibitors of prolactin release by rat cultured anterior pituitary cells. Mol Endocrinol 8:1278-1287.
24. Allinquant B, Hantraye P, Mailleux P, Moya K, Bouillot C, Prochiantz A. 1995. Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J Cell Biol 128:919-927.
25. Elliott G, O'Hare P. 1997. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88:223-233.
26. Elliott G, Mouzakitis G, O'Hare P. 1995. VP16 interacts via its activation domain with VP22, a tegument protein of herpes simplex virus, and is relocated to a novel macromolecular assembly in coexpressing cells. J Virol 69:7932-7941.
27. Elliott G, O'Reilly D, O'Hare P. 1996. Phosphorylation of the herpes simplex virus type 1 tegument protein VP22. Virology 226:140-145.
28. Blaho JA, Mitchell C, Roizman B. 1994. An amino acid sequence shared by the herpes simplex virus 1 α regulatory proteins 0, 4, 22, and 27 predicts the nucleotidylation of the UL21, UL31, UL47, and UL49 gene products. J Biol Chem 269:17401-17410.
29. Knopf KW, Kaerner HC. 1980. Virus-specific basic phosphoproteins associated with herpes simplex virus type a (HSV-1) particles and the chromatin of HSV-1-infected cells. J Gen Virol 46:405-414.
30. Elliott G, O'Hare P. 1998. Herpes simplex virus type 1 tegument protein VP22 induces the stabilization and hyperacetylation of microtubules. J Virol 72:6448-6455.
31. van Leeuwen H, Elliott G, O'Hare P. 2002. Evidence of a role for nonmuscle myosin II in herpes simplex virus type 1 egress. J Virol 76: 3471-3481.
32. Kueltzo LA, Normand N, O'Hare P, Middaugh CR. 2000. Conformational lability of herpes virus protein VP22. J Biol Chem 276:33213-33221.
33. Sciortino MT, Taddeo B, Poon AP, Mastino A, Roizman B. 2002. Of the three tegument proteins that package mRNA in herpes simplex virions, one (VP22) transports the mRNA to uninfected cells for expression prior to viral infection. Proc Natl Acad Sci USA 99:8318-8323.
34. Derer W, Easwaran HP, Knopf CW, Leonhardt H, Cardoso MC. 1999. Direct protein transfer to terminally differentiated muscle cells. J Mol Med 77:609-613.
35. Aints A, Dilber MS, Smith CIE. 1999. Intercellular spread of GFP-VP22. J Gene Med 1:275-279.
36. Phelan A, Elliott G, O'Hare P. 1998. Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotech 16:440-443.
37. Wybranietz WA, Prinz F, Speigel M, Schenk A, Bitzer M, Gregor M, Lauer UM. 1999. Quantification of VP22-GFP spread by direct fluorescence in 15 commonly used cell lines. J Gene Med 1:265-274.
38. Derer W, Easwaran HP, Leonhardt H, Cardoso MC. 2002. A novel approach to induce cell cycle reentry in terminally differentiated muscle cells. FASEB J 16:132-133.
39. Dilber MS, Phelan A, Aints A, Mohamed AJ, Elliott G, Edvard Smith CI, O'Hare P. 1999. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther 6:12-21.
40. Wybranietz WA, Gross CD, Phelan A, O'Hare P, Spiegel M, Graepler F, Bitzer M, Stahler P, Gregor M, Lauer UM. 2001. Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene. Gene Ther 8:1654-1664.
41. Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Polo JM, Slater LA, Ling M, Wu TC. 2002. Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion. Hum Gene Ther 13:553-568.
42. Lai Z, Brady RO. 2002. Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector. J Neurosci Res 67:363-371.
43. Lai Z, Han I, Zirzow G, Brady RO, Reiser J. 2000. Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors. Proc Natl Acad Sci USA 97: 11297-11302.
44. Wills KN, Atencio IA, Avanzini JB, Neuteboom S, Phelan A, Philopena J, Sutjipto S, Vaillancourt MT, Wen SF, Ralston RO, Johnson DE. 2001. Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus. J Virol 75:8733-8741.
45. Normand N, van Leeuwen H, O'Hare P. 2001. Particle formation by a conserved domain of the herpes simplex virus protein VP22 facilitating protein and nucleic acid delivery. J Biol Chem 276:15042-15050.
46. Aints A, Guven H, Gahrton G, Smith CI, Dilber MS. 2001. Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting. Gene Ther 8:1051-1056.
47. Kueltzo LA. 2002. Molten globule-lipid bilayer interactions and their implications for protein transport. In: An investigation into the role of molten globule-like states in non-classical protein transport. Doctoral Thesis. Lawrence, KS: University of Kansas, pp 207-242.
48. Middaugh CR, Volkin D, Thomas K. 1993. Acidic and basic fibroblast growth factors. Curr Opin Invest Drugs 2:991-1005.
49. Volkin DB, Middaugh CR. 1996. The characterization, stabilization, and formulation of acidic fibroblast growth factor. In: Pearlman R, Wang YJ, editors. Formulation, characterization, and stability of protein drugs. New York: Plenum Press, pp 181-217.
50. Miyakawa K, Hatsuzawa K, Kurokawa T, Asada M, Kuroiwa T, Imamura T. 1999. A hydrophobic region locating at the center of fibroblast growth factor-9 is crucial for its secretion. J Biol Chem 274:29352-29357.
51. Ornitz DM, Itoh N. 2001. Fibroblast growth factors. Genome Biol 2: Reviews 3005.1-3005.12.
52. Volkin DB, Tsai PK, Dabora JM, Gress JO, Burke CJ, Linhardt RJ, Middaugh CR. 1993. Physical stabilization of acidic fibroblast growth factor by polyanions. Arch Biochem Biophys 300:30-41.
53. Copeland RA, Ji H, Halfpenny AJ, Williams RW, Thompson KC, Herber WK, Thomas KA, Bruner MW, Ryan JA, Marquis-Omer D, Sanyal G, Sitrin RD, Yamazaki S, Middaugh CR. 1991. The structure of human acidic fibroblast growth factor and its interaction with heparin. Arch Biochem Biophys 289:53-61.
54. Stauber DJ, DiGabriele AD, Hendrickson WA. 1999. Structural interactions of fibroblast growth factor receptor with its ligands. Proc Natl Acad Sci USA 97:49-54.
55. Plotnikov AN, Schlessinger J, Hubbard SR, Mohammadi M. 1999. Structural basis for FGF receptor dimerization and activation. Cell 98: 641-650.
56. Jackson A, Friedman S, Zhan X, Engleka KA, Forough R, Maciag T. 1992. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc Natl Acad Sci USA 89:10691-10695.
57. Piotrowicz RS, Martin JL, Dillman WH, Levin EG. 1997. The 27-kDa heat shock protein facilitates basic fibroblast growth factor release from endothelial cells. J Biol Chem 272:7042-7047.
58. Tarantini F, LaVallee T, Jackson A, Gamble S, Carreira CM, Garfinkel S, Burgess WH, Maciag T. 1998. The extravesicular domain of synaptotagmin-1 is released with the latent fibroblast growth factor-1 homodimer in response to heat shock. J Biol Chem 273:22209-22216.
59. Landriscina M, Soldi R, Bagala C, Micucci I, Bellum S, Tarantini F, Prodovsky I, Maciag T. 2001. S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro. J Biol Chem 276:22544-22552.
60. Edwards K, Kueltzo L, Fisher M, Middaugh C. 2001. Complex effects of molecular chaperones on the aggregation and refolding of fibroblast growth factor-1. Arch Biochem Biophys 393:14-21.
61. Prudovsky I, Bagala C, Tarantini F, Mandinova A, Soldi R, Bellum S, Maciag T. 2002. The intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export. J Cell Biol 158:201-208.
62. Citores L, Wesche J, Kolpakova E, Olsnes S. 1999. Uptake and intracellular transport of acidic fibroblast growth factor: Evidence for free and cytoskeleton-anchored fibroblast growth factor receptors. Mol Biol Cell 10:3835-3848.
63. Lin Y-Z, Yao S, Hawinger J. 1996. Role of the nuclear localization sequence in fibroblast growth factor-1-stimultaed mitogenic pathways. J Biol Chem 271:5305-5308.
64. Cao Y, Ekstrom M, Pettersson R. 1993. Characterization of the nuclear translocation of acidic fibroblast growth factor. J Cell Sci 104:77-87.
65. Zhan X, Hu X, Friedman S, Maciag T. 1992. Analysis of endogenous and exogenous nuclear translocation of fibroblast growth factor-1 in NIH 3T3 cells. Biochem Biophys Res Commun 188: 982-991.
66. Klein S, Carroll JA, Chen Y, Henry MF, Henry PA, Ortonowski IE, Pintucci G, Beavis RC, Burgess WH, Rifkin DB. 2000. Biochemical analysis of the arginine methylation of high molecular weight fibroblast growth factor-2. J Biol Chem 275:3150-3157.
67. Gawiak S, Pastan I, Siegall C. 1993. Basic fibroblast growth factor-Pseudomonas exotoxin chimeric proteins; Comparison with acidic fibroblast growth factor-Pseudomonas exotoxin. Bioconj Chem 4:483-489.
68. Siegall CB, Epstein S, Speir E, Hla T, Forough R, Maciag T, Fitzgerald DJ, Pastan I. 1991. Cytotoxic activity of chimeric proteins composed of acidic fibroblast growth factor and Pseudomonas exotoxin on a variety of cell types. FASEB J 5:2843-2849.
69. Siegall CB, Gawlak SL, Chace DF, Merwin JR, Pastan I. 1994. In vivo activities of acidic fibroblast growth factor-Pseudomonas exotoxin fusion proteins. Bioconj Chem 5:77-83.
70. Wiedlocha A, Madshus IH, Mach H, Middaugh CR, Olsnes S. 1992. Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diptheria toxin as vector. EMBO J 11:4835-4842.
71. Dikov MM, Reich MB, Dworkin L, Thomas JW, Miller GG. 1998. A functional fibroblast growth factor-1 immunoglobulin fusion protein. J Biol Chem 273:15811-15817.
72. Vemuri S, Beylin I, Sluzky V, Stratton P, Eberlein G, Wang YJ. 1994. The stability of bFGF against thermal denaturation. J Pharm Pharmacol 46: 481-486.
73. Mach H, Middaugh CR. 1995. Interaction of partially structured states of acidic fibroblast growth factor with phospholipid membranes. Biochemistry 34:9913-9920.
74. Jeang K-T, Xiao H, Rich EA. 1999. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem 274:28837-28840.
75. Frankel AD, Pabo CO. 1988. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55:1189-1193.
76. Green M, Loewenstein PM. 1988. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55:1179-1188.
77. Mann DA, Frankel AD. 1991. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J 10:1733-1739.
78. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67:277-287.
79. Albini A, Benelli R, Presta M, Rusnati M, Ziche M, Rubartelli A, Paglialunga G, Bussolino F, Noonan D. 1996. HIV-tat protein is a heparin-binding angiogenic growth factor. Oncogene 12:289-297.
80. Vives E, Brodin P, Lebleu B. 1997. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272: 16010-16017.
81. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. 1999. In vivo protein transduction: Delivery of a biologically active protein into the mouse. Science 285:1569-1572.
82. Caron NJ, Torrente Y, Camirand G, Bujold M, Chapdelaine P, Leriche K, Bresolin N, Tremblay JP. 2001. Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol Ther 3:310-318.
83. Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Gius DR, Wei MC, Dowdy SF. 1997. Hypophosphorylation of the retinoblastoma protein (pRb) by cyclin D: Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci USA 94:10699-10704.
84. Li H, Yao Z, Degenhardt B, Teper G, Papadopoulos V. 2001. Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci USA 98:1267-1272.
85. Astriab-Fisher A, Sergueev D, Fisher M, Shaw BR, Juliano RL. 2002. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: Effects on cellular uptake, binding to target sequences, and biologic actions. Pharm Res 19:744-754.
86. Eguchi A, Akuta T, Okuyama H, Senda T, Yokoi H, Inokuchi H, Fujita S, Hayakawa T, Takeda K, Hasegawa M, Nakanishi M. 2001. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem 276:26204-26210.
87. Torchilin VP, Rammohan R, Weissig V, Levchenko TS. 2001. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA 98:8786-8791.
88. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. 2000. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18:410-414.
89. Bayley H. 1999. Protein therapy-delivery guaranteed. Nat Biotech 17:1066-1067.
90. Silhol M, Tyagi M, Giacca M, Lebleu B, Vives E. 2002. Different mechanisms for cellular internalization of the HIV-1 Tat- derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem 269:494-501.
91. Rusnati M, Tulipano G, Spillmann D, Tanghetti E, Oreste P, Zoppetti G, Giacca M, Presta M. 1999. Multiple interactions of HIV-1 Tat protein with size-defined heparin oligosaccharides. J Biol Chem 274:28198-28205.
92. Tyagi M, Rusnati M, Presta M, Giacca M. 2000. Internalization of HIV-1 TAT requires cell surface heparan sulfate proteoglycans. J Biol Chem 276:3254-3261.
93. Suzuki T, Futaki S, Niwa M, Tanaka S, Ueda K, Sugiura Y. 2002. Possible existence of common internalization mechanisms among arginine-rich peptides. J Biol Chem 277:2437-2443.
94. Bonifaci N, Sitia R, Rubartelli A. 1995. Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding. AIDS 9: 995-1000.
95. Schwarze SR, Hruska KA, Dowdy SF. 2000. Protein transduction: Unrestricted delivery into all cells? Trends Cell Biol 10:290-295.
96. Schwarze SR, Dowdy SF. 2000. In vivo protein transduction: Intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci 21:45-48.
97. Ho A, Schwarze SR, Mermelstein SJ, Waksman G, Dowdy SF. 2001. Synthetic protein transduction domains: Enhanced transduction potential in vitro and in vivo. Cancer Res 61:474-477.
98. Drin G, Demene H, Temsamani J, Brasseur R. 2001. Translocation of the pAntp peptide and its amphipathic analogue AP-2AL. Biochemistry 40: 1824-1834.
99. Perez F, Joliot A, Bloch-Gallego E, Zahraoui A, Triller A, Prochiantz A. 1992. Antennapedia homeobox as a signal for the cellular internalization and nuclear addressing of a small exogenous peptide. J Cell Sci 102:717-722.
100. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A. 1996. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 271:18188-18193.
101. Derossi D, Joliot AH, Chassaing G, Prochaintz A. 1994. The third helix of the Antennapedia Homeodomain translocates through biological membranes. J Biol Chem 269:10444-10450.
102. Derossi D, Chassaing G, Prochiantz A. 1998. Trojan peptides: The penetratin system for intracellular delivery. Trends Cell Biol 8:84-87.
103. Bonfanti M, Taverna S, Salmona M, D'Incalci M, Broggini M. 1997. p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res 57:1442-1446.
104. Giorello L, Clerico L, Pescarolo MP, Vikhanskaya F, Salmona M, Colella G, Bruno S, Mancuso T, Bagnasco L, Russo P, Parodi S. 1998. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Cancer Res 58:3654-3659.
105. Pooga M, Soomets U, Hallbrink M, Valkna A, Saar K, Rezaei K, Kahl U, Hao JX, Xu XJ, Wiesenfeld-Hallin Z, Hokfelt T, Bartfai T, Langel U. 1998. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol 16:857-861.
106. Braun K, Peschke P, Pipkorn R, Lampel S, Wachsmuth M, Waldeck W, Friedrich E, Debus J. 2002. A biological transporter for the delivery of peptide nucleic acids (PNAs) to the nuclear compartment of living cells. J Mol Biol 318:237-243.
107. Kilk K, Magzoub M, Pooga M, Eriksson LE, Langel U, Graslund A. 2001. Cellular internalization of a cargo complex with a novel peptide derived from the third helix of the islet-1 homeodomain. Comparison with the penetratin peptide. Bioconj Chem 12:911-916.
108. Schutze-Redelmeier MP, Gournier H, Garcia-Pons F, Moussa M, Joliot AH, Volovitch M, Prochiantz A, Lemonnier FA. 1996. Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo. J Immunol 157:650-655.
109. Chatelin L, Volovitch M, Joliot AH, Perez F, Prochiantz A. 1996. Transcription factor hoxa-5 is taken up by cells in culture and conveyed to their nuclei. Mech Dev 55:111-117.
110. Joliot A, Trembleau A, Raposo G, Calvet S, Volovitch M, Prochiantz A. 1997. Association of Engrailed homeoproteins with vesicles presenting caveolae-like properties. Development 124:1865-1875.
111. Joliot A, Maizel A, Rosenberg D, Trembleau A, Dupas S, Volovitch M, Prochiantz A. 1998. Identification of a signal sequence necessary for the unconventional secretion of Engrailed homeoprotein. Curr Biol 8:856-863.
112. Wadia JS, Dowdy SF. 2002. Protein transduction technology. Curr Opin Biotechnol 13:52-56.
113. Hawiger J. 1997. Cellular import of functional peptides to block intracellular signaling. Curr Opin Immunol 9:189-194.
114. Hawiger J. 1999. Noninvasive intracellular delivery of functional peptides and proteins. Curr Opin Chem Biol 3:89-94.
115. Schwartz JJ, Zhang S. 2000. Peptide-mediated cellular delivery. Curr Opin Mol Ther 2:162-167.
116. Dunican DJ, Doherty P. 2001. Designing cell-permeant phosphopeptides to modulate intracellular signaling pathways. Biopolymers 60:45-60.
117. Barry MA, Dower WJ, Johnston SA. 1996. Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 2:299-305.
118. Oess S, Hildt E. 2000. Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens. Gene Ther 7:750-758.
119. Langedijk JP. 2002. Translocation activity of C-terminal domain of pestivirus Erns and ribotoxin L3 loop. J Biol Chem 277:5308-5314.
120. Pooga M, Hallbrink M, Zorko M, Langel U. 1998. Cell penetration by transportan. FASEB J 12: 67-77.
121. Oehlke J, Scheller A, Wiesner B, Krause E, Beyermann M, Klauschenz E, Melzig M, Bienert M. 1998. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim Biophys Acta 1414:127-139.
122. Elmquist A, Lindgren M, Bartfai T, Langel U. 2001. VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp Cell Res 269:237-244.
123. Han K, Jeon MJ, Kim SH, Ki D, Bahn JH, Lee KS, Park J, Choi SY. 2001. Efficient intracellular delivery of an exogenous protein GFP with genetically fused basic oligopeptides. Mol Cells 12: 267-271.
124. Morris MC, Depollier J, Mery J, Heitz F, Divita G. 2001. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19:1173-1176.
125. Chen L, Wright LR, Chen CH, Oliver SF, Wender PA, Mochly-Rosen D. 2001. Molecular transporters for peptides: Delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). Chem Biol 8:1123-1129.
126. Vogt TC, Bechinger B. 1999. The interactions of histidine-containing amphipathic helical peptide antibiotics with lipid bilayers. The effects of charges and pH. J Biol Chem 274:29115-29121.
127. Blau S, Jubeh TT, Haupt SM, Rubinstein A. 2000. Drug targeting by surface cationization. Crit Rev Ther Drug Carrier Syst 17:425-465.
128. Fang B, Xu B, Koch P, Roth JA. 1998. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells. Gene Ther 5:1420-1424.
129. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B. 2003. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 278:585-590.
130. Ptitsyn OB. 1995. Molten globule and protein folding. Adv Protein Chem 47:83-229.
131. Bychkova VE, Pain RH, Ptitsyn OB. 1988. The "molten globule" state is involved in the translocation of proteins across membranes? FEBS Lett 238:231-234.
132. Mach H, Ryan JA, Burke CJ, Volkin DB, Middaugh CR. 1993. Partially structured self-associating states of acidic fibroblast growth factor. Biochemistry 32:7703-7711.
133. Oh KJ, Senzel L, Collier RJ, Finkelstein A. 1999. Translocation of the catalytic domain of diphtheria toxin across planar phospholipid bilayers by its own T domain. Proc Natl Acad Sci USA 96: 8467-8470.
134. Sanyal G, Marquis-Omer D, Gress JO, Middaugh CR. 1993. A transforming growth factor-alpha-Pseudomonas exotoxin hybrid protein undergoes pH-dependent conformational changes conducive to membrane interaction. Biochemistry 32:3488-3497.
135. Chenal A, Savarin P, Nizard P, Guillain F, Gillet D, Forge V. 2002. Membrane protein insertion regulated by bringing electrostatic and hydrophobic interactions into play.A case study with the translocation domain of the diphtheria toxin. J Biol Chem 277:43425-43432.
136. Ren J, Sharpe JC, Collier RJ, London E. 1999. Membrane translocation of charged residues at the tips of hydrophobic helices in the T domain of diphtheria toxin. Biochemistry 38:976-984.
137. Nykypanchuk D, Strey HH, Hoagland DA. 2002. Brownian motion of DNA confined within a two-dimensional array. Science 297:987-990.
138. Ren J, Kachel K, Kim H, Malenbaum SE, Collier RJ, London E. 1999. Interaction of diphtheria toxin T domain with molten globule-like proteins and its implications for translocation. Science 284:955-957.
139. Bogdanov M, Dowhan W. 1999. Lipid-assisted protein folding. J Biol Chem 274:36827-36830.
140. Bogdanov M, Umeda M, Dowhan W. 1999. Phospholipid-assisted refolding of an integral membrane protein. Minimum structural features for phosphatidylethanolamine to act as a molecular chaperone. J Biol Chem 274:12339-12345.
141. van der Goot FG, Gonzalez-Manas JM, Lakey JH, Pattus F. 1991. A "molten-globule" membrane-insertion intermediate of the pore-forming domain of colicin A. Nature 354:408-410.
142. Shin I, Kreimer D, Silman I, Weiner L. 1997. Membrane-promoted unfolding of acetylcholinesterase: A possible mechanism for insertion into the lipid bilayer. Proc Natl Acad Sci USA 94: 2848-2852.
143. Dabora JM, Sanyal G, Middaugh CR. 1991. Effect of polyanions on the refolding of human acidic fibroblast growth factor. J Biol Chem 266:23637-23640.
144. Richardson TP, Trinkaus-Randall V, Nugent MA. 1999. Regulation of basic fibroblast growth factor binding and activity by cell density and heparan sulfate. J Biol Chem 274:13534-13540.
145. Rusnati M, Coltrini D, Oreste P, Zoppetti G, Albini A, Noonan D, di Fagagna F, Giacca M, Presta M. 1997. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. J Biol Chem 272:11313-11320.
146. Rusnati M, Tulipano G, Urbinati C, Tanghetti E, Giuliani R, Giacca M, Ciomei M, Corallini A, Presta M. 1998. The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists. J Biol Chem 273:16027-16037.
147. Persson D, Thoren PE, Herner M, Lincoln P, Norden B. 2003. Application of a novel analysis to measure the binding of the membrane-translocating Peptide penetratin to negatively charged liposomes. Biochemistry 42:421-429.
148. Wiethoff CM, Smith JG, Koe GS, Middaugh CR. 2001. The potential role of proteoglycans in cationic lipid-mediated gene delivery. Studies of the interaction of cationic lipid-DNA complexes with model glycosaminoglycans. J Biol Chem 276: 32806-32813.
149. Dom G, Shaw-Jackson C, Matis C, Bouffioux O, Picard JJ, Prochiantz A, Mingeot-Leclercq MP, Brasseur R, Rezsohazy R. 2003. Cellular uptake of Antennapedia Penetratin peptides is a two-step process in which phase transfer precedes a tryptophan-dependent translocation. Nucleic Acids Res 31:556-561.
150. Boudon S, Wipff G, Maigret B. 1990. Monte Carlo simulations on the like-charged guanidinium-guanidinium ion pair in water. J Phys Chem 94: 6056-6061.
151. Burley SK, Petsko GA. 1988. Weakly polar interactions in proteins. Adv Protein Chem 39:125-189.
152. Karlin S, Zuker M, Brocchieri L. 1994. Measuring residue associations in protein structures. Possible implications for protein folding. J Mol Biol 239:227-248.
153. Brocchieri L, Karlin S. 1994. Geometry of interplanar residue contacts in protein structures. Proc Natl Acad Sci USA 91:9297-9301.
154. Gebhardt K, Lauvrak V, Babaie E, Eijsink V, Lindqvist BH. 1996. Adhesive peptides selected by phage display: Characterization, applications and similarities with fibrinogen. Peptein Res 9:269-278.
155. Park J, Ryu J, Kim KA, Lee HJ, Bahn JH, Han K, Choi EY, Lee KS, Kwon HY, Choi SY. 2002. Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells. J Gen Virol 83:1173-1181.
156. Mitchell DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB. 2000. Polyarginine enters cells more efficiently than other polycationic homopolymers. J Peptide Res 56:318-325.
157. Prochiantz A. 1996. Getting hydrophilic compounds into cells: Lessons from homeopeptides. Curr Opin Neurobiol 6:629-634.
158. Prochiantz A. 1999. Homeodomain-derived peptides. In and out of the cells. Ann NY Acad Sci 886:172-179.
159. Berlose JP, Convert O, Derossi D, Brunissen A, Chassaing G. 1996. Conformational and associative behaviours of the third helix of antennapedia homeodomain in membrane-mimetic environments. Eur J Biochem 242:372-386.
160. Koltover I, Salditt T, Radler JO, Safinya CR. 1998. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 281:78-81.
161. Safinya CR. 2001. Structures of lipid-DNA complexes: Supramolecular assembly and gene delivery. Curr Opin Struct Biol 11:440-448.
162. Kuchler K. 1993. Unusual routes of protein secretion: The easy way out. Trends Cell Biol 3: 421-426.
163. Kuchler K, Egner R. 1997. Unusual protein secretion and translocation pathways in yeast: Implication of ABC transporters. In: Kuchler K, editor. Unusual secretory pathways: From bacteria to man. Austin, TX: R.G. Landes, pp 49-86.
164. Acosta JA, Benzaquen LR, Goldstein DJ, Tosteson MT, Halperin JA. 1996. The transient pore formed by homologous terminal complement complexes functions as a bidirectional route for the transport of autocrine and paracrine signals across human cell membranes. Mol Med 2:755-765.
165. Terlecky SR, Dice JF. 1993. Polypeptide import and degradation by isolated lysosomes. J Biol Chem 268:23490-23495.
166. Andrei C, Dazzi C, Lotti L, Torrisi MR, Chimini G, Rubartelli A. 1999. The secretory route of the leaderless protein interleukin lbeta involves exocytosis of endolysosome-related vesicles. Mol Biol Cell 10:1463-1475.
167. Drin G, Mazel M, Clair P, Mathieu D, Kaczorek M, Temsamani J. 2001. Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinity. Eur J Biochem 268:1304-1314.
168. Fink AL. 1999. Chaperone-mediated protein folding. Physiol Rev 79:425-449.
169. Pollack GH. 2001. Cells, gels and the engines of life; A new, unifying approach to cell function. Seattle, WA: Ebner and Sons, pp 11-37.
170. Subczynski WK, Wisniewska A. 2000. Physical properties of lipid bilayer membranes: Relevance to membrane biological functions. Acta Biochim Pol 47:613-625.
171. Xiang T, Anderson BD. 2000. Influence of a transmembrane protein on the permeability of small molecules across lipid membranes. J Membr Biol 173:187-201.
172. Yuen CT, Davidson AR, Deber CM. 2000. Role of aromatic residues at the lipid-water interface in micelle-bound bacteriophage M13 major coat protein. Biochemistry 39:16155-16162.
173. Tsang S, Saier MH Jr. 1996. A simple flexible program for the computational analysis of amino acyl residue distribution in proteins: Application to the distribution of aromatic versus aliphatic hydrophobic amino acids in transmembrane alpha-helical spanners of integral membrane transport proteins. J Comput Biol 3:185-190.
174. Espanol MJ, Saier MH Jr. 1995. Topological and segmental phylogenetic analyses of the anion exchanger (band 3) family of transporters. Mol Membr Biol 12:193-200.
175. Ma JC, Dougherty DA. 1997. The cation-π interaction. Chem Rev 97:1303-1324.
176. Kim CS, Kweon DH, Shin YK. 2002. Membrane topologies of neuronal SNARE folding intermediates. Biochemistry 41:10928-10933.
177. Call ME, Pyrdol J, Wiedmann M, Wucherpfennig KW. 2002. The organizing principle in the formation of the T cell receptor-CD3 complex. Cell 111: 967-979.
178. Gratkowski H, Lear JD, DeGrado WF. 2001. Polar side chains drive the association of model transmembrane peptides. Proc Natl Acad Sci USA 98:880-885.
179. Zhou FX, Merianos HJ, Brunger AT, Engelman DM. 2001. Polar residues drive association of polyleucine transmembrane helices. Proc Natl Acad Sci USA 98:2250-2255.